Kewaunee Scientific (NASDAQ:KEQU) Announces Quarterly Earnings Results

Kewaunee Scientific (NASDAQ:KEQU) issued its quarterly earnings results on Wednesday. The technology company reported $0.58 earnings per share for the quarter, Zacks reports. The firm had revenue of $66.32 million for the quarter. Kewaunee Scientific had a return on equity of 11.75% and a net margin of 2.97%.

Kewaunee Scientific Trading Down 1.4%

Shares of NASDAQ:KEQU opened at $34.53 on Friday. The company has a current ratio of 2.18, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53. Kewaunee Scientific has a 12-month low of $32.00 and a 12-month high of $48.17. The company has a market capitalization of $99.10 million, a PE ratio of 12.51 and a beta of 0.73. The business’s fifty day simple moving average is $36.69 and its 200-day simple moving average is $37.09.

Institutional Investors Weigh In On Kewaunee Scientific

A number of hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE boosted its stake in shares of Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares during the period. US Bancorp DE raised its stake in Kewaunee Scientific by 80.0% during the third quarter. US Bancorp DE now owns 900 shares of the technology company’s stock valued at $38,000 after buying an additional 400 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Kewaunee Scientific during the 2nd quarter valued at about $60,000. Barclays PLC bought a new position in shares of Kewaunee Scientific during the 4th quarter valued at about $92,000. Finally, Jane Street Group LLC lifted its stake in Kewaunee Scientific by 65.8% in the 1st quarter. Jane Street Group LLC now owns 8,052 shares of the technology company’s stock worth $317,000 after acquiring an additional 3,196 shares in the last quarter. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Kewaunee Scientific in a research note on Tuesday, June 30th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of “Hold”.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.